Samsung's Ontruzant Becomes First Trastuzumab Biosimilar Approved In EU

 
• By Jung Won Shin
  
Samsung Bioepis
Samsung Bioepis researchers conducting a study • Source: Samsung Bioepis
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products